Indsoya Ltd

Dematerialisation processing and listing

• Securities received for dematerialisation were confirmed to the depositories (accepted/rejected) by the RTA.
• The dematerialised securities have been listed on the stock exchanges where the earlier issued securities are listed.
• Physical certificates received for dematerialisation were mutilated and cancelled after due verification.
• The depository's name was substituted in the register of members as registered owner within prescribed timelines.

Apollo Ingredients Limited (Formerly known as Indsoya Limited) – Closure of Trading Window from 1 October 2026 till 48 hours after the declaration of the unaudited financial statements for the quarter and half year ending 30 September 2026

Appointment details

• Palak Jain Kothari appointed as Company Secretary and Compliance Officer, designated as Key Managerial Personnel.
• Appointment takes effect from October 01, 2026.
• Board approved the appointment on September 22, 2026 on Nomination and Remuneration Committee recommendation.
• Qualified Company Secretary; ICSI Associate Member; Membership No. A81711.
• Not related to any Directors.
• Role designated as Key Managerial Personnel.

CS/KMP changes

• Ayushi Agrawal resigns as Company Secretary and Compliance Officer effective 1 October 2026.
• Palak Jain Kothari appointed as Company Secretary, Compliance Officer, and KMP from 1 October 2026.
• Regulation 30 disclosures to Annexures I and II filed.

Governance policy approvals

• Board approved revised policies for Independent Directors, Code of Conduct and related party transactions.
• Policies include Whistle Blower, materiality of events, and related party transaction framework.

Strategic discussions

• EPDs across the value chain discussed to enhance sustainability and competitiveness.
• Explored government contracts and tenders opportunities.
• Considered backward integration in healthcare for growth.

Meeting details & disclosures

• Board meeting held on 22 September 2026 from 04:00 PM to 07:00 PM.
• Annexures I and II provide detailed regulatory disclosures.

Meeting Details

• 22 September 2026, 04:00 PM; Venue: Registered Office, Mittal Enclave, Juchandra, Vasai, Maharashtra 401208.

Key Agenda Items

• Discuss Environmental Product Declarations (EPDs) across the value chain.
• Explore participation in government contracts and tenders.
• Assess backward integration diversification into the healthcare industry.
• Consider any other matter with the Chair's permission.

Financial highlights

• Total income from operations: 526.87 Lakh in Q1 FY27.
• Total revenue (1+2) for quarter ended 30-06-2026: 526.87 Lakh.
• PAT after tax: 121.62 Lakh; prior quarter: -8.87 Lakh.
• EPS (basic/diluted): Rs 1.17 for the quarter.
• Total expenses: 405.25 Lakh; major items include purchases 478.53, finished goods -111.44.
• Paid-up equity share capital: 520 Lakh.

Unaudited quarterly results

• Quarter ended 30 June 2026: standalone unaudited results approved
• Total income 526.87 Lakh; net profit after tax 121.62 Lakh

Major governance decisions

• Media Things & Communications appointed advertising agency, effective 10 August 2026
• Trading window for Designated Persons remains closed until 12 August 2026

Regulatory / auditor matters

• Statutory auditors express unqualified opinion on results for year ended 30 June 2026

Meeting Details

• Date/time: 10 August 2026, 04:00 PM; Registered Office, Mittal Enclave Building-6 A Wing A-1, Juchandra, Vasai, Maharashtra 401208.

Key Agenda Items

• Consider and take on record the unaudited financial results for quarter ended 30 June 2026.
• Any other matter with the permission of the Chair.

Other Notes

• No trading window closure period is specified.